ArticleCureus2026
Arteriovenous Hemangiomas: A Manifestation of Chronic Liver Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatologic abnormalities are common in patients with hepatic disorders, with the skin being one of the major target organs for extrahepatic manifestations. Common skin findings in liver disease include spider angiomas, palmar erythema, caput medusa, and nail changes. This report details a case of arteriovenous hemangiomas in a patient with alcohol-induced chronic liver disease. The patient received an orthotopic liver transplant, and follow-up 10 weeks later showed a marked reduction in the size of the arteriovenous hemangiomas as well as significant improvement of spider angiomas. Abnormal skin findings can be the first patient-reported symptoms or findings on exam. The marked reduction in this patient's arteriovenous hemangiomas after liver transplantation supports prior evidence that treating underlying liver disease leads to arteriovenous hemangioma regression. While most cutaneous conditions are asymptomatic, familiarity and prompt recognition of common and uncommon skin changes of liver dysfunction, including arteriovenous hemangiomas, are important for early diagnosis and treatment initiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.